United States

Arno Therapeutics Inc (ARNI.PK)

ARNI.PK on OTC Markets Group

21 Jul 2017
Change (% chg)

$0.01 (+28.71%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Arno Therapeutics reports Q1 adj loss of $0.05 per share
Monday, 16 May 2016 05:05pm EDT 

Arno Therapeutics Inc :Q1 adjusted non-gaap loss per share $0.05.  Full Article

Arno Therapeutics Inc announces resignation of chief operating officer and chief financial officer - Form 8-K
Friday, 11 Sep 2015 04:32pm EDT 

Arno Therapeutics Inc:Says that on Sept. 4, Lawrence A. Kenyon, chief operating officer and chief financial officer of Arno Therapeutics Inc, provided written notice to the company that he is resigning his employment with the company, effective as of Sept. 15.  Full Article

No consensus analysis data available.